Xeljanz
- RxCUI
- 1357542
- RxNorm name
- Xeljanz
- Term type
- BN
- Status
- Active
- Updated
- 2026-07-24 06:52:01
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 122012
- Active start
- 122012
- Multiple ingredient
- NO
- Branded
- YES
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| tofacitinib | 1357536 |
Source Vocabulary Codes#
UNII Substances#
No records found.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
No records found.
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | L04AF | Janus-associated kinase (JAK) inhibitors | ATC1-4 | tofacitinib | |
| FDASPL | N0000190858 | Janus Kinase Inhibitor | EPC | has_epc | tofacitinib |
| FDASPL | N0000190857 | Janus Kinase Inhibitors | MOA | has_moa | tofacitinib |
| MEDRT | D010880 | Piperidines | CHEM | has_ingredient | tofacitinib |
| MEDRT | D010880 | Piperidines | CHEM | has_ingredient | tofacitinib citrate |
| MEDRT | D011743 | Pyrimidines | CHEM | has_ingredient | tofacitinib |
| MEDRT | D001172 | Arthritis, Rheumatoid | DISEASE | may_treat | tofacitinib |
| MEDRT | D001172 | Arthritis, Rheumatoid | DISEASE | may_treat | tofacitinib citrate |
| MEDRT | N0000190857 | Janus Kinase Inhibitors | MOA | has_moa | tofacitinib |
| MEDRT | N0000190857 | Janus Kinase Inhibitors | MOA | has_moa | tofacitinib citrate |
| MEDRT | N0000008656 | Decreased Hematopoiesis | PE | has_pe | tofacitinib |
| MEDRT | N0000008656 | Decreased Hematopoiesis | PE | has_pe | tofacitinib citrate |
| MEDRT | N0000175550 | Decreased Immunologic Activity | PE | has_pe | tofacitinib |
| MEDRT | N0000175550 | Decreased Immunologic Activity | PE | has_pe | tofacitinib citrate |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | BN_CARDINALITY | single |
| ATTRIBUTES | GENERAL_CARDINALITY | SINGLE |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| SOURCES | Source | Multum MediSource Lexicon |